Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Stem Cells SpinWAR:SCS +8.64%38 Days Inventory is 54,841.25 as of Mar. 2026, which is 429% above its 10-year median of 10,359.92. GuruFocus rates WAR:SCS with a GF Score™ of 38/100 and a GF Value™ of zł0.10 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 637 Biotechnology companies, Stem Cells Spin ranks worse than 98.9% on this metric.
The historical rank and industry rank for Stem Cells Spin's Days Inventory or its related term are showing as below:
WAR:SCS'
s Days Inventory Range Over the Past 10 Years
Min: 2796.97 Med: 10359.92 Max: 43362
Current: 12162.61
During the past 13 years, Stem Cells Spin's highest Days Inventory was 43362.00. The lowest was 2796.97. And the median was 10359.92.
WAR:SCS's Days Inventory is ranked worse than 98.9% of 637
companies
in the Biotechnology industry
Industry Median: 180.38
vs WAR:SCS: 12162.61
Stem Cells Spin's Days Inventory
increased
from Mar. 2025 (53,974.38) to Mar. 2026 (54,841.25).
It might indicate that Stem Cells Spin's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Stem Cells Spin's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.00.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Stem Cells Spin's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 85.86.
Stem Cells Spin (WAR:SCS) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Stem Cells Spin's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Stem Cells Spin's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Stem Cells Spin Days Inventory Related Terms
Stem Cells Spin Days Inventory Historical Data
* Premium members only.
The historical data trend for Stem Cells Spin's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:SCS vs VRTX, REGN, RVMD: Days Inventory Comparison
For the Biotechnology subindustry, Stem Cells Spin's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stem Cells Spin Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Stem Cells Spin's Days Inventory distribution charts can be found below:
* The bar in red indicates where Stem Cells Spin's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stem Cells Spin (WAR:SCS) has a Days Inventory of 54,841.25 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Stem Cells Spin and its competitors. This is 429% above median its historical median of 10,359.92. Over the past decade, Stem Cells Spin's Days Inventory has ranged from 2,796.97 to 43,362.00. According to the industry distribution chart, Stem Cells Spin ranks #630 out of 637 companies in the Biotechnology industry, placing it in the top 98.9%.
Is Stem Cells Spin's Days Inventory too high?
Stem Cells Spin's current Days Inventory of 54,841.25 is 429% above median its 10-year median of 10,359.92. Over the past 10 years, this metric has ranged from a low of 2,796.97 to a high of 43,362.00. The Biotechnology industry median Days Inventory is 180.38. Stem Cells Spin's value of 54,841.25 is 30303.2% above this industry median. Based on the distribution chart, Stem Cells Spin ranks #630 out of 637 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Stem Cells Spin has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Stem Cells Spin's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Stem Cells Spin ranks #630 out of 637 companies for Days Inventory. This places Stem Cells Spin in the lower half of its industry. The industry median Days Inventory is 180.38. Stem Cells Spin's value of 54,841.25 is 30303.2% above this benchmark. Historically, Stem Cells Spin's own Days Inventory has ranged from 2,796.97 to 43,362.00 over the past decade. While the company's 10-year median is 10,359.92 vs. the industry median of 180.38, Stem Cells Spin has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 180.38, based on 637 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Stem Cells Spin's current Days Inventory of 54,841.25 is 30303.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Stem Cells Spin and its competitors. For the Biotechnology industry, the median Days Inventory is 180.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stem Cells Spin's current Days Inventory is 54,841.25, which is 429% above median its own 10-year median of 10,359.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stem Cells Spin stock overvalued right now?
Based on GuruFocus' analysis, Stem Cells Spin (WAR:SCS) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.10, compared to a current price of zł0.48 — trading 378% above its estimated fair value. The current Days Inventory is 54,841.25, which is 429% above median its 10-year median of 10,359.92 and 30303.2% above the Biotechnology industry median of 180.38. Stem Cells Spin's overall GF Score™ is 38/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Stem Cells Spin (WAR:SCS), the current Days Inventory is 54,841.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stem Cells Spin (WAR:SCS) Overvalued in 2026?
Based on GuruFocus' analysis, Stem Cells Spin stock appears to be overvalued.
The current stock price of zł0.48 is trading 378% above its estimated GF Value™ of zł0.10.
GuruFocus considers Stem Cells Spin to be Significantly Overvalued.
Key valuation signals for WAR:SCS:
Days Inventory: 54,841.25 (429% above median its 10-year median of 10,359.92)
GF Value™: zł0.10 vs. price of zł0.48 (378% above fair value)
Industry Position: 30303.2% above the Biotechnology median (#630 of 637)
No single metric tells the full story. See the WAR:SCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stem Cells Spin SA is a biotechnology company. The company is engaged in the development, production, marketing, and sale of natural regenerative products for the dermocosmetic and veterinary care markets, as well as applications for the human and veterinary medical industry. Its products include NHAC Biocervin MIC-1, Revitacell, PRS MIC-1, and Velvetyna.
38GF Score
Get the complete analysis for WAR:SCS
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:SCS has been successfully added to your 
